Other
Dexamethasone Palmitate
0
Pipeline Programs↗
3
Active Trials↗
0
Companies Involved↗
Dexamethasone Palmitate is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
4
clinical trials
Recruiting2 · 50%
Not yet recruiting1 · 25%
Completed1 · 25%
Clinical Trials
Trial Activity
Dexamethasone Palmitate for PONV After Open Surgery
Recruiting·—·N/A·NCT06997419·500 enrolled
Dexamethasone Palmitate for Postoperative Pain
Not yet recruiting·—·N/A·NCT07341854·446 enrolled
Preemptive Co-infiltration of Dexamethasone Palmitate With Ropivacaine for Postoperative Pain in Major Spinal Surgery
Completed·—·Phase 4·NCT05693467·124 enrolled
Dexamethasone Palmitate for PONV After Craniotomy
Recruiting·—·N/A·NCT06988124·500 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)